A randomized study of the value of dosimetry in the use of 131I for ablation of post. operative thyroid remnants.

被引：0
|
作者：
Silberstein, EB [1 ]
机构：
[1] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2001年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1358.1
引用
收藏
页码：350P / 350P
页数：1
相关论文
共 50 条
  • [31] Post-Surgical 131I Ablation in Patients with Papillary Thyroid Cancer: The Role of Diagnostic 123I Whole Body Scan
    Iagaru, A.
    Mosci, C.
    Akatsu, H.
    Basina, M.
    Dosiou, C.
    McDougall, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S235 - S235
  • [32] Undetectable ablation thyroglobulin in patients with differentiate thyroid cancer showing 131I uptake on post-ablation therapy whole-body scan
    Alban, F.
    Guelho, D.
    Costa, G.
    Albuquerque, A.
    Pedroso de Lima, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S547 - S547
  • [33] Timing of post 131I ablation diagnostic whole body scan in differentiated thyroid cancer patients Less than four months post ablation may be too early
    Winter, M.
    Winter, J.
    Heinzel, A.
    Behrendt, F. F.
    Krohn, T.
    Mottaghy, F. M.
    Verburg, F. A.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (04): : 151 - 157
  • [34] The MEDIRAD multi-national I-131 dosimetry study for thyroid ablation and adjuvant therapy: current status
    Leek, F.
    Taprogge, J.
    Gregory, R.
    Newbold, K.
    Verburg, F.
    Luster, M.
    Schurrat, T.
    Trans-Gia, J.
    Eberlein, U.
    Lapa, C.
    Buck, A. K.
    Lassmann, M.
    Mora-Ramirez, E.
    Vergara-Gil, A.
    Bardies, M.
    Vallot, D.
    Courbon, F.
    Vija, L.
    Flux, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S194 - S195
  • [35] The effect of post-ablation 131I SPECT/CT on the staging and initial risk-stratification of children with differentiated thyroid cancer
    Liu, Bin
    Tian, Rong
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [36] The effect of post-ablation 131I SPECT/CT on the staging and initial risk-stratification of children with differentiated thyroid cancer
    Liu, B.
    Tian, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S220 - S220
  • [37] Absorbed dose to blood from high dose 131I ablation therapy for metastatic thyroid cancer calculated by individual curve fitting and biological dosimetry.
    Li, MH
    Bom, HS
    Song, HC
    Kim, SM
    Heo, YJ
    Kim, JY
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 355P - 355P
  • [38] Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of 131I
    Atkins, Frank
    Van Nostrand, Douglas
    Moreau, Shari
    Burman, Kenneth
    Wartofsky, Leonard
    THYROID, 2015, 25 (12) : 1347 - 1350
  • [39] Value of post-therapeutic 131I scintigraphy in stimulated serum thyroglobulin-negative patients with metastatic differentiated thyroid carcinoma
    Chen-Tian Shen
    Wei-Jun Wei
    Zhong-Ling Qiu
    Hong-Jun Song
    Quan-Yong Luo
    Endocrine, 2016, 51 : 283 - 290
  • [40] Value of post-therapeutic 131I scintigraphy in stimulated serum thyroglobulin-negative patients with metastatic differentiated thyroid carcinoma
    Shen, Chen-Tian
    Wei, Wei-Jun
    Qiu, Zhong-Ling
    Song, Hong-Jun
    Luo, Quan-Yong
    ENDOCRINE, 2016, 51 (02) : 283 - 290
12345